C.L.K. Stevens

489 total citations
25 papers, 416 citations indexed

About

C.L.K. Stevens is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, C.L.K. Stevens has authored 25 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in C.L.K. Stevens's work include Computational Drug Discovery Methods (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and HER2/EGFR in Cancer Research (5 papers). C.L.K. Stevens is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and HER2/EGFR in Cancer Research (5 papers). C.L.K. Stevens collaborates with scholars based in United States and China. C.L.K. Stevens's co-authors include Jayalakshmi Sridhar, Maryam Foroozesh, Jiawang Liu, Richard L. Schroeder, Vivian Haley‐Zitlin, Linnea R. Freeman, Naijue Zhu, Ann‐Charlotte Granholm, Ping Jin and Edwin D. Stevens and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and Chemical Research in Toxicology.

In The Last Decade

C.L.K. Stevens

25 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.L.K. Stevens United States 10 149 133 106 86 76 25 416
Larry J. Jolivette United States 12 115 0.8× 141 1.1× 106 1.0× 70 0.8× 73 1.0× 20 400
Hequn Yin United States 11 188 1.3× 194 1.5× 65 0.6× 161 1.9× 35 0.5× 20 508
Rebecca B. White United States 14 218 1.5× 198 1.5× 47 0.4× 124 1.4× 181 2.4× 27 636
Eiji Kashiyama Japan 12 134 0.9× 185 1.4× 55 0.5× 100 1.2× 210 2.8× 24 623
Kaushik Mitra United States 15 126 0.8× 197 1.5× 71 0.7× 56 0.7× 228 3.0× 31 516
Nicola E. Wilsher United Kingdom 13 69 0.5× 421 3.2× 61 0.6× 104 1.2× 120 1.6× 20 742
A.I. Archakov Russia 11 138 0.9× 156 1.2× 56 0.5× 56 0.7× 38 0.5× 45 370
L. Chastine Bell United States 6 293 2.0× 162 1.2× 58 0.5× 144 1.7× 34 0.4× 7 447
Natalie Hosea United States 9 110 0.7× 99 0.7× 119 1.1× 70 0.8× 31 0.4× 9 298
Susan Petusky United States 9 52 0.3× 225 1.7× 101 1.0× 162 1.9× 126 1.7× 10 567

Countries citing papers authored by C.L.K. Stevens

Since Specialization
Citations

This map shows the geographic impact of C.L.K. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L.K. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L.K. Stevens more than expected).

Fields of papers citing papers by C.L.K. Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L.K. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L.K. Stevens. The network helps show where C.L.K. Stevens may publish in the future.

Co-authorship network of co-authors of C.L.K. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of C.L.K. Stevens. A scholar is included among the top collaborators of C.L.K. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L.K. Stevens. C.L.K. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ofori‐Boadu, Andrea, et al.. (2020). Learning Experiences and Self-efficacy of Minority Middle-School Girls during a "Bio-char Modified Cement Paste" Research Program at an HBCU. Papers on Engineering Education Repository (American Society for Engineering Education). 2 indexed citations
3.
Stevens, C.L.K., et al.. (2015). Do children increase their environmental consciousness during summer camp? A comparison of two programs. Journal of Outdoor Recreation Education and Leadership. 7(1). 20–34. 8 indexed citations
4.
Schroeder, Richard L., C.L.K. Stevens, & Jayalakshmi Sridhar. (2014). Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer. Molecules. 19(9). 15196–15212. 76 indexed citations
5.
Sridhar, Jayalakshmi, et al.. (2013). Development of Flavone Propargyl Ethers as Potent and Selective Inhibitors of Cytochrome P450 Enzymes 1A1 and 1A2. Drug Metabolism Letters. 6(4). 275–284. 18 indexed citations
6.
Sridhar, Jayalakshmi, et al.. (2013). Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer. Bioorganic & Medicinal Chemistry Letters. 24(1). 126–131. 8 indexed citations
7.
Sridhar, Jayalakshmi, et al.. (2013). Abstract B058: Drug resistant HER2Δ16 overexpression cells are sensitive to a new class of tyrosine kinase inhibitors. Molecular Cancer Research. 11(10_Supplement). B058–B058. 1 indexed citations
8.
Liu, Jiawang, Jayalakshmi Sridhar, Xiaoyi Zhang, et al.. (2012). 7-Ethynylcoumarins: Selective Inhibitors of Human Cytochrome P450s 1A1 and 1A2. Chemical Research in Toxicology. 25(5). 1047–1057. 25 indexed citations
9.
Sridhar, Jayalakshmi, Jiawang Liu, Maryam Foroozesh, & C.L.K. Stevens. (2012). Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies. Molecules. 17(8). 9283–9305. 39 indexed citations
10.
Freeman, Linnea R., Vivian Haley‐Zitlin, C.L.K. Stevens, & Ann‐Charlotte Granholm. (2011). Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutritional Neuroscience. 14(1). 32–44. 39 indexed citations
11.
Stevens, C.L.K., et al.. (2011). Sulfapyridine (polymorph III), sulfapyridine dioxane solvate, sulfapyridine tetrahydrofuran solvate and sulfapyridine piperidine solvate, all at 173 K. Acta Crystallographica Section C Crystal Structure Communications. 67(12). o487–o491. 13 indexed citations
12.
Sridhar, Jayalakshmi, Jiawang Liu, Maryam Foroozesh, & C.L.K. Stevens. (2011). Inhibition of Cytochrome P450 Enzymes by Quinones and Anthraquinones. Chemical Research in Toxicology. 25(2). 357–365. 45 indexed citations
13.
Stevens, C.L.K. & Jayson Seaman. (2010). SEER at Age 9: Past, Present, and Future. Journal of Experiential Education. 32(3). 327–331. 1 indexed citations
14.
Jiang, Quan, Florastina Payton‐Stewart, Steven Elliott, et al.. (2010). Effects of 7-O Substitutions on Estrogenic and Anti-Estrogenic Activities of Daidzein Analogues in MCF-7 Breast Cancer Cells. Journal of Medicinal Chemistry. 53(16). 6153–6163. 44 indexed citations
15.
Haley‐Zitlin, Vivian, et al.. (2010). Development and Implementation of a Service Learning Departmental Initiative in a Department of Food Science and Human Nutrition. Journal of the American Dietetic Association. 110(9). A102–A102. 1 indexed citations
16.
Zhu, Naijue, Jiawang Liu, Maryam Foroozesh, et al.. (2009). Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450. Journal of Chemical Crystallography. 40(4). 343–352. 7 indexed citations
17.
McGee, Terri L., et al.. (2007). Methoxyflavone Inhibitors of Cytochrome P450. Journal of Chemical Crystallography. 38(4). 231–237. 8 indexed citations
18.
Zhu, Naijue, et al.. (2007). Tyrphostin Tumor Growth Inhibitors of EGFR and ErbB2 Tyrosine Kinase. Journal of Chemical Crystallography. 37(10). 679–683. 1 indexed citations
19.
Zhu, Naijue, et al.. (2006). Naphthoflavone propargyl ether inhibitors of cytochrome P450. Journal of Chemical Crystallography. 36(5). 289–296. 6 indexed citations
20.
Zhu, Naijue, C.L.K. Stevens, & Edwin D. Stevens. (2005). An experimental charge density study of mesulergine hydrochloride, a dopamine agonist. Journal of Chemical Crystallography. 35(1). 13–22. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026